Being tested
Ketamine: improve symptoms or function in MS (type not specified)
MS (type not specified) · Pain, mood, cognition and other symptoms
Trials are running now and no controlled trial has a readable result yet.
- Trials
- 3
- Running now
- 1
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
No controlled trial has reported a result yet.
Other linked trials: 3
Dose comparisons, trials against another medicine, add-on trials, phase 1 and uncontrolled studies. They are listed below but do not set the status.
Trials
Other linked trials: 3
These linked trials do not set the status.
- INKLING-MSOngoing
Phase 2 · 2023 · Not randomised
- Ketamine for Treatment of MS FatigueNo result found
Phase 1/2 · 2018 · Placebo-controlled
- Ketamine for MS FatigueResult in a paper, not read yet
Phase early 1 · 2023 · Placebo-controlled
The deciding phase and counts come from the Trial Bank’s fixed rules.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- 2026-10-27First listed as Being tested
Related hypotheses
- Pain, mood, cognition and other symptoms: improve symptoms or function in MS (type not specified)
- Donepezil: improve symptoms or function in MS (type not specified)
- Duloxetine: improve symptoms or function in MS (type not specified)
- Escitalopram: improve symptoms or function in MS (type not specified)
- Gabapentin: improve symptoms or function in MS (type not specified)
- Lidocaine: improve symptoms or function in MS (type not specified)
- Pregabalin: improve symptoms or function in MS (type not specified)
- Rivastigmine: improve symptoms or function in MS (type not specified)
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error